Somewhere in your building there may be a high-fidelity patient simulator under a dust cover. It blinks, breathes, has a pulse and cost as much as a small car. It also runs six times a year, because nobody was funded to write scenarios for it, nobody was trained to debrief, and the one educator who knew how to power it up moved to another unit. That manikin is not a training asset. It is a depreciating exhibit.
The question facility leaders reach for is "high fidelity or low fidelity?" It is the wrong question, and it is expensive to get wrong. The right question is narrower and far more useful: what is the least realistic tool that will meet this specific learning objective, and can we use it often enough to justify what it costs to own?
This guide is for the person who signs the purchase order and defends the line item. It explains what each tier of the fidelity spectrum genuinely buys, why the sticker price is the smallest part of the cost, why utilization decides return more than realism does, and where simulation budgets quietly leak. None of it requires clinical judgment to act on. All of it decides whether your spend produces competent staff or a covered manikin.
Fidelity means how closely a simulation reproduces reality. The International Nursing Association for Clinical Simulation and Learning, whose Healthcare Simulation Standards of Best Practice are the reference most accredited programs work from, describes it in more than one dimension: physical fidelity (does it look and feel like the real thing), conceptual fidelity (do the cause-and-effect relationships hold together), and psychological fidelity (does the learner behave as they would with a real patient). The last one is the one that actually drives learning, and it is the one money buys least directly.
That distinction matters because "high fidelity" in a vendor brochure almost always means physical fidelity: more sensors, more realistic skin, a wider menu of programmable signs. Physical realism is genuinely useful for some objectives and irrelevant for others. A learner can reach full psychological fidelity, fully immersed and behaving as they would on a live unit, while practicing on a simple part-task trainer, if the scenario around it is designed well and the facilitator holds the frame.
So fidelity is not a quality rating. It is a specification, like resolution or horsepower, that is worth paying for only when the objective needs it. The competent buyer treats the fidelity spectrum as a menu to match against goals, not a ladder to climb toward the most expensive rung.
Task trainers are the workhorses: an arm for venous access practice, a torso for compressions, a pad for suturing. They buy repetition of a single skill at very low cost per attempt, and they tolerate being run hard by large groups with light supervision. For building and maintaining hand skills, nothing on the spectrum is more cost-effective, and no facility should be spending high-fidelity money to teach a task a trainer teaches better.
Mid-fidelity manikins add basic physiologic feedback: breath sounds, a palpable pulse, a rhythm on a monitor. They buy the bridge between an isolated skill and a patient with a story, letting learners connect an assessment finding to an action without the full cost or complexity of a high-fidelity platform.
High-fidelity manikins buy dynamic physiology that responds to what the learner does or fails to do. That responsiveness is what makes them worth their price for a narrow set of objectives: recognizing a deteriorating patient, prioritizing under pressure, and running a coordinated team response. If your objective is any of those, the realism earns its keep. If it is not, you are paying for capability you will not use.
Standardized patients, trained people who portray a case consistently, buy something no manikin does well: authentic human interaction. They are the right tool for communication, cultural humility, breaking difficult news and de-escalation. In-situ simulation, run on the real unit with real equipment, buys system insight, surfacing the latency in your own environment, the missing supplies and broken handoffs, that a lab can never reveal.
The number on the quote is the number leaders anchor to, and it is the least important cost in the room. Total cost of ownership, the figure that should actually drive the decision, includes the recurring lines that outlast the purchase many times over.
The largest of those, in almost every program, is people. Every scenario a manikin runs consumes preparation, delivery and, above all, debriefing time from trained educators. Debriefing is not the wrap-up; the evidence and the INACSL standards both treat it as the core of the intervention, the phase where reflection converts an experience into changed practice. A program that buys a manikin and does not fund the facilitator hours to run and debrief it has bought a prop.
Then come the recurring hard costs: warranty and service contracts on complex electronics, consumables replaced every session, software licensing and updates, the IT support the platform quietly assumes, and dedicated space that could otherwise generate revenue, plus storage for everything between sessions. The illustration below shows the shape budget-holders repeatedly discover: acquisition is a slice, and the operating lines are the pie.
Two facilities buy the identical high-fidelity manikin. One runs it twice a month with a trained facilitator and a validated scenario library; the other runs it during one annual skills week. They paid the same acquisition price and received wildly different value, because the real unit of cost is not the purchase, it is the cost per competent learner produced.
Spread the total cost of ownership across the encounters the asset actually delivers and the arithmetic becomes obvious. An expensive platform used constantly can be cheaper per encounter than a modest one that sits idle, and a task trainer run weekly is one of the best returns in the building. Low utilization is the single most common way simulation money is wasted, and it is almost always a scheduling and staffing problem, not an equipment problem.
This is also why the buy decision and the operating plan cannot be separated. If you cannot describe, before the purchase, who will run the asset, how often, and against which objectives, you are not ready to buy it. The same discipline underlies any honest attempt at measuring the return on clinical training: cost per outcome, not cost per device.
The leaks are predictable, and every one of them is a management decision rather than a technology failure.
The most influential data point in this field is the National Simulation Study run by the National Council of State Boards of Nursing. In a large, multi-site, randomized study, programs that substituted up to half of their traditional clinical hours with high-quality simulation produced graduates whose licensure pass rates, clinical competency and readiness for practice were comparable to peers with conventional clinical time. That finding reshaped how regulators think about simulation.
The detail budget-holders should hold onto is the phrase "high-quality." The study did not conclude that expensive manikins substitute for clinical time. It concluded that well-designed simulation, run by trained facilitators, using standardized scenarios and adequate resources, does. Outcomes tracked with program quality, not with raw fidelity. The money that mattered went into design and people, not only into hardware.
For nursing programs specifically, this has a regulatory edge in Texas. The Texas Board of Nursing's education rules permit simulation to substitute for a defined share of clinical hours when a program follows the NCSBN simulation guidelines and meets the associated faculty and resource conditions. Confirm the current percentage and the exact conditions in the Board's education rules before you build a curriculum or a business case around them, because that share is a rule that can be updated. Whether you are a school protecting clinical placements or a hospital closing a competency gap, the lesson is the same one that runs through Wahero's view of how simulation builds confident clinicians: design and debriefing are the investment, and realism is a tool in service of them.
Reduced to a sequence, a defensible simulation purchase looks like this, and none of it depends on the sales cycle of a vendor.
Start with the competency gap and write the objective before you look at any product. Choose the lowest tier of fidelity that meets that objective honestly. Budget the whole total cost of ownership, not the quote, with facilitator time as an explicit line. Confirm utilization before purchase: name the sessions, the calendar and the staff who will run them. Fund facilitator development as seriously as the equipment. Then measure a baseline and an outcome so the next cycle is an evidence-based decision rather than a repeat of the last brochure.
That framework is deliberately boring, and boring is what protects a budget. It also reframes the classic build-or-buy question, because whether you develop this capability in-house or bring it in, the cost drivers are identical. Our honest comparison of contract versus in-house training works through that decision on the same cost-structure terms.
Is high-fidelity simulation always the best investment for a facility? No. Fidelity should match the learning objective. Psychomotor and procedural skills are learned efficiently on low-cost task trainers, while clinical judgment, deterioration recognition and team communication justify high-fidelity manikins or standardized patients. Paying for realism the objective does not require adds cost without adding learning. The reliable value driver is how heavily the equipment is used and how well the sessions are facilitated, not the price tag on the manikin.
What is the largest hidden cost of a simulation program? Facilitator and educator time, in almost every program. A high-fidelity manikin is a one-time purchase, but every scenario it runs consumes prep, delivery and debriefing hours from trained staff. Warranty and service contracts, consumables, software, storage and dedicated space add further recurring costs. Budgeting the purchase price alone routinely understates the true cost of ownership by a wide margin.
How much clinical time can simulation replace in a nursing program? The landmark NCSBN National Simulation Study found that programs substituting up to half of traditional clinical hours with high-quality simulation produced graduates with comparable NCLEX pass rates, clinical competency and readiness for practice. The Texas Board of Nursing's education rules permit simulation to substitute for a defined share of clinical hours when the program follows the NCSBN simulation guidelines. Confirm the current percentage and conditions in the Board's education rules before you plan around them.
Wahero Health Institute designs and delivers simulation as a program, not a product: objectives first, the right fidelity for each, trained facilitation, and debriefing that turns a session into changed practice. Explore our simulation lab and on-site events, or talk to us about matching the spend to your facility's real competency gaps.
Related reading
Educational content only
This material is published by Wahero Health Institute for professional education and is not individual medical advice, a care protocol, or a substitute for clinical judgment. Always follow your facility's policies, your state's nurse practice act, and your own scope of practice, and confirm medication doses against a current authoritative reference before administration. See our Terms of Use.
